THE SMART TRICK OF AZELAPRAG BIOAGE THAT NOBODY IS DISCUSSING

Azelaprag was perfectly tolerated Within this study and in any respect doses analyzed so far in 227 topics, with a security profile per the results of prior phase one trials executed by Amgen.We are excited about the opportunity to collaborate with BioAge to share Lilly’s skills in incretins, and make the most of our Chorus clinical enhancement m